Titan Pharmaceuticals Inc (TTNP) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Titan Pharmaceuticals Inc   (NASDAQ: TTNP)


Titan Pharmaceuticals Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Titan Pharmaceuticals Inc's ROI in the second quarter of 2025?
Titan Pharmaceuticals Inc recorded a cumulative net loss of $-3 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -108.55%.

Within the Healthcare sector 728 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 3876 to 4202.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM -58.42 % -41.79 % 17.01 % 141.93 % 560.89 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 3 2 2 3 4
Return On Investment (TTM) -108.55 % -145.87 % -119.5 % -117.99 % -87.88 %
TTNP's Overall Ranking # 4202 # 3876 # 3452 # 3960 # 2746
Seq. Investment Change TTM -10.45 % -26.73 % -21.06 % -19.72 % 25.36 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -3 -4 -5 -6 -5

TTNP Company Profile >> Back to TTNP Roi Comparisons >> See Annual TTNP Return On Investment



Return On Investment TTNP's Ranking
Within: No.
Industry # 121
Sector # 729
Overall # 4202

Return On Investment Statistics
High Average Low
53.29 %
-173.09 %
-900.29 %
(Jun 30 2016)   (Jun 30 2023)



  News about Titan Pharmaceuticals Inc Return on Investment ROI

Titan Pharmaceuticals Regains NASDAQ Compliance and Works Towards Enhanced Financial Performance

January 25, 2024

Titan Pharmaceuticals Regains Compliance With NASDAQ Listing Criteria and Works Toward Improved ROI
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) has recently announced that it has successfully regained compliance with the minimum $1.00 bid price requirement, marking a positive development for the company. In a letter dated January 24, 2024, The Nasdaq Stock Market LLC confirmed that Titan meets all applicable criteria for continued listing on The Nasdaq Capital Market. As a result, the listing matter has been closed, relieving any concerns about potential delisting.
This news comes after the company faced financial challenges, recording a cumulative net loss of $-6 million during the 12-month period ending in the third quarter of 2023. Consequently, Titan experienced a negative return on investment (ROI) of -298.98%. While these figures may seem concerning, it s noteworthy that within the Healthcare sector, 897 other companies managed to achieve a higher ROI.





Financial Statements
Titan Pharmaceuticals Inc's II. Quarter Investments $ 3 Millions TTNP's Balance sheet
Titan Pharmaceuticals Inc's II. Quarter Income $ -1 Millions Quarterly TTNP's Income Statement
TTNP's Income by Division See TTNP's Income by Division


TTNP Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 2 7 1 5 4
Y / Y Investment Growth -63.26 % 365.13 % -73.18 % 37.81 % -34.75 %
Net Income in Millions -5 -6 -10 -9 -18
Y / Y Net Income Growth - - - - -
Annual Return On Investment -192.87 % -83.85 % -714.71 % -164.81 % -472.1 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TTNP's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TTNP's Competitors
Subscribers only: Roi for Titan Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for TTNP's Customers

Other Ratios
TTNP's Roa TTNP's Inventory Turnover Ratio TTNP's Growth Rates TTNP's Dividend Statistics
TTNP's Profitability Ratios TTNP's Asset Turnover Ratio TTNP's Dividend Growth
TTNP's Roe TTNP's Valuation Ratios TTNP's Financial Strength Ratios TTNP's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-08-29T17:31:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.